Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 5671 to 5685 of 7707 results

  1. How can needle and syringe programmes encourage specific groups of people who inject drugs to use the service effectively? Examples include: those who have recently started injecting; women; sex workers; ex-prisoners; people who are homeless; people who occasionally inject drugs; and people who inject novel psychoactive drugs.

    Recommendation ID PH52/1 Question How can needle and syringe programmes encourage specific groups of people who inject drugs to use the

    Research recommendation
    Published
    9 June 2015

  2. How can outcome measures relating to workplace health and wellbeing be measured?

    Recommendation ID NG13/2 Question How can outcome measures relating to workplace health and wellbeing be measured? Any explanatory

    Research recommendation
    Published
    5 October 2015

  3. Relapse prevention after enforced, temporary quit: How can people who have recently stopped or temporarily abstained from smoking in a smokefree inpatient or treatment environment be best supported after discharge to prevent relapse or to stop permanently?

    Recommendation ID NG209/12 Question Relapse prevention after enforced, temporary quit: How can people who have recently stopped or temporarily

    Research recommendation
    Published
    17 December 2021

  4. Support for people with mental health conditions to stop smoking: How can people with mental health conditions be supported effectively to stop smoking (at individual and system level)? What are the challenges and opportunities and how can they be addressed?

    Recommendation ID NG209/04 Question Support for people with mental health conditions to stop smoking: How can people with mental health

    Research recommendation
    Published
    17 December 2021

  5. System leadership and service delivery: How can practitioners, institutions and organisations work together to improve systems leadership that impacts collectively on positive outcomes for children and young people's social, emotional and mental wellbeing?

    Recommendation ID NG223/05 Question System leadership and service delivery: How can practitioners, institutions and organisations work

    Research recommendation
    Published
    4 August 2022

  6. For people with favourable aneurysm morphology needing an EVAR as a primary procedure, evidence on the safety of using endoanchoring systems is adequate. However, evidence on efficacy is inadequate in quantity and quality. Therefore, for these people, this procedure should only be used in the context of research. Find out what only in research means on the NICE interventional procedures guidance page.

    Recommendation ID IPG725/02 Question For people with favourable aneurysm morphology needing an EVAR as a primary procedure, evidence on

    Research recommendation
    Published
    1 June 2022

  7. For people with alcohol dependence, which medication is most likely to improve adherence and thereby promote abstinence and prevent relapse?

    Recommendation ID CG115/6 Question For people with alcohol dependence, which medication is most likely to improve adherence and thereby

    Research recommendation
    Published
    9 June 2015

  8. For people with generalised anxiety disorder (GAD) who are ready to start a low-intensity intervention, what is the clinical effectiveness of physical activity compared with waiting-list control?

    Recommendation ID CG113/3 Question For people with generalised anxiety disorder (GAD) who are ready to start a low-intensity intervention

    Research recommendation
    Published
    9 June 2015

  9. Antiplatelet therapy: For people with CKD at the highest risk of cardiovascular disease, what is the clinical effectiveness of low-dose aspirin compared with placebo for primary prevention of cardiovascular disease?

    Recommendation ID NG203/19 Question Antiplatelet therapy: For people with CKD at the highest risk of cardiovascular disease, what is the

    Research recommendation
    Published
    30 September 2021

  10. Thyroid peroxidase antibody testing: For people with indeterminate cytopathology, what is the clinical and cost effectiveness of thyroid peroxidase antibody testing?

    Recommendation ID NG230/06 Question Thyroid peroxidase antibody testing: For people with indeterminate cytopathology, what is the clinical

    Research recommendation
    Published
    6 January 2023

  11. Surgical excision for people with lentigo maligna: For people with lentigo maligna (stage 0 in sun damaged skin, usually on the face) how effective is Mohs micrographic surgery, compared with excision with a 0.5 cm clinical margin, in preventing biopsy proven local recurrence at 5 years? This should be investigated in a randomised controlled trial. Secondary outcomes should include cosmetic and functional outcomes.

    Recommendation ID NG14/08 Question Surgical excision for people with lentigo maligna: For people with lentigo maligna (stage 0 in sun damaged

    Research recommendation
    Published
    4 August 2022

  12. For people with mild or moderate tricuspid regurgitation, evidence on the safety and efficacy of transcatheter tricuspid valve annuloplasty is inadequate in quantity and quality. Therefore, for these people, this procedure should only be used in the context of research. Find out what only in research means on the NICE interventional procedures guidance page.

    Recommendation ID IPG730/02 Question For people with mild or moderate tricuspid regurgitation, evidence on the safety and efficacy of transcatheter

    Research recommendation
    Published
    4 August 2022

  13. For people with mild or moderate tricuspid regurgitation, evidence on the safety and efficacy of transcatheter tricuspid valve leaflet repair is inadequate in quantity and quality. Therefore, for these people, this procedure should only be used in the context of research. Find out what only in research means on the NICE interventional procedures guidance page.

    Recommendation ID IPG731/02 Question For people with mild or moderate tricuspid regurgitation, evidence on the safety and efficacy of transcatheter

    Research recommendation
    Published
    5 August 2022

  14. Is response to pharmacological treatment predicted more reliably by underlying aetiology or by symptom characteristics?

    Recommendation ID CG173/2 Question Is response to pharmacological treatment predicted more reliably by underlying aetiology or by symptom

    Research recommendation
    Published
    26 October 2020

  15. NICE may update this guidance after 3 years or sooner if important new information becomes available, including evidence on: the epidemiology of CJD, including data on the prevalence of CJD and its infectivity in the UK population the transmission of CJD by surgical instruments, including cases of CJD in which surgery is a possible route of transmission the cost effectiveness of single-use instruments for use in interventional procedures on high-risk tissues commercially available decontmination methods that are safe and cost effective against prions the systems for, and cost effectiveness of, maintaining set integrity and traceability of instruments.

    Recommendation ID IPG666/1 Question NICE may update this guidance after 3 years or sooner if important new information becomes available

    Research recommendation
    Published
    10 February 2020